ANTIBODIES AGAINST PD-1 AND USES THEREFOR

摘要

This disclosure provides antibodies and antigen-binding fragments that can a ct as agonists and/or antagonists of PD-1 (Programmed Death 1), thereby modulating immune responses in general, and those mediated by TcR and CD28, in particular. The disclosed compositions and methods may be used for example, in treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer, and other immune system disorders.